Intrinsic Imaging Awarded Cardiovascular Clinical Trial

San Antonio (TX), Bolton (MA), (PRWEB) January 31, 2012 — Intrinsic Imaging, an ISO 9001:2008 certified medical imaging core lab providing clinical image management and radiological review services in support of pharmaceutical, biotechnology, medical device and clinical research organizations, announces today that it was recently awarded an important Cardiovascular Clinical Trial.

Over the duration of this clinical trial, Intrinsic Imaging will provide its cardiovascular imaging expertise to evaluate the product's clinical safety and effectiveness. This trial, which will be managed from Intrinsic Imaging's San Antonio office, consists of 1500 reviews.

Intrinsic Imaging's team of more than sixty board-certified diagnostic radiologists have extensive experience in all therapeutic areas including cardiovascular disease. Its cardiovascular imaging team includes board-certified radiologists with cardiovascular training and multiple modality expertise including ultrasound, nuclear imaging, positron emission tomography (PET), invasive angiography, magnetic resonance imaging (MRI), and computed tomography (CT) including novel techniques such as Adenosine Stress MRI.

According to the World Health Organization, cardiovascular diseases are the number one cause of death globally. In 2008, an estimated 17.3 million people died from cardiovascular diseases representing 30% of all global deaths. By 2030, it is estimated that almost 23.6 million people will die from cardiovascular diseases and they are projected to remain the single leading causes of death.

"Due to the significant global impact of Cardiovascular disease on the population, there is increasing development of new therapeutics in this field and these each require clinical assessment. At Intrinsic Imaging, our teams have specialized training and expertise in adult and pediatric cardiovascular disease and are readily able to provide clinical image management and radiological review for cardiovascular clinical trials." said Todd A. Joron, BSc. MBA, President and Chief Operating Officer, Intrinsic Imaging.